MICHAEL G. BATOR - 18 May 2022 Form 4 Insider Report for Cytosorbents Corp (CTSO)

Role
Director
Signature
/s/ Kathleen P. Bloch attorney-in-fact Michael G. Bator
Issuer symbol
CTSO
Transactions as of
18 May 2022
Net transactions value
+$24,130
Form type
4
Filing time
19 May 2022, 07:01:36 UTC
Next filing
12 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTSO Common Stock Purchase $4,360 +2,000 +2.7% $2.18 75,800 18 May 2022 Direct
transaction CTSO Common Stock Purchase $4,360 +2,000 +2.6% $2.18 77,800 18 May 2022 Direct
transaction CTSO Common Stock Purchase $4,400 +2,000 +2.6% $2.20 79,800 18 May 2022 Direct
transaction CTSO Common Stock Purchase $4,400 +2,000 +2.5% $2.20 81,800 18 May 2022 Direct
transaction CTSO Common Stock Purchase $4,400 +2,000 +2.4% $2.20 83,800 18 May 2022 Direct
transaction CTSO Common Stock Purchase $2,210 +1,000 +1.2% $2.21 84,800 18 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (a) the following restricted stock units which will vest upon a "Change of Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan: (i) 3,300 restricted stock units granted on March 15, 2018, (ii) 6,000 restricted stock units granted on February 24, 2017, and (iii) 60,000 restricted stock units granted on June 7, 2017, and (b) 15,500 shares of common stock owned by the reporting person, inclusive of 11,000 total shares of common stock purchased on May 18, 2022 and reported on this Form 4.